Cor Vasa 2018, 60(5):e487-e492 | DOI: 10.1016/j.crvasa.2017.10.010

Giant-cell myocarditis - A case report and a brief review

Jan Látal^a, Miloslav Špaček^a,*, Jan Přeček^a, Zbyněk Tüdös^b, Martin Hutyra^a, Tomáš Tichý^c, Miloš Táborský^a

^a I. interní klinika - kardiologická, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc, Česká republika

^b Radiologická klinika, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc, Česká republika

^c Ústav klinické a molekulární patologie, Lékařská fakulta Univerzity Palackého a Fakultní nemocnice Olomouc, Olomouc, Česká republika

Giant-cell myocarditis is an extremely rare disease with high morbidity and mortality. In the majority of cases, the course of the disease is in the form of fulminant myocarditis. The cornerstone of the treatment is aggressive immunosuppresive therapy in addition to heart failure treatment, however, the need for mechanical circulatory support or heart transplant is high. In our case report, we present a patient suffering from giant-cell myocarditis, who, despite rapid diagnosis and prompt aggressive treatment, died shortly after heart transplant.

Keywords: 2D longitudinal strain; Fulminant myocarditis; Giant-cell myocarditis

Received: September 11, 2017; Revised: October 21, 2017; Accepted: October 24, 2017; Published: October 1, 2018  Show citation